Perrot, A., Hulin, C., Lambert, J., Karlin, L., Arnulf, B., Rey, P., Garderet, L., Macro, M., Barbe, M. E., Gay, J., Chalopin, T., Gounot, R., Colella, J. M. S. D., Mohty, M., Leleu, X. P., Manier, S., Avet-Loiseau, H., Corre, J., Moreau, P., Touzeau, C. (2025). MRD-driven strategy following IsaKRD induction in transplant-eligible NDMM: Primary endpoints of the phase 3 MIDAS trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7500